Autoimmune diseases are known for being critical to handle and treat, but today, with the advancements in modern medicines ...

Often uveitis or iritis inflammatory conditions of the eye can also occur in IBD patients. These are important to recognize. A lot of times the most prominent symptom is really intense photophobia ...

Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – ...

Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

A concentration of 8.0 µg/ml or greater was associated with a shorter duration of clinical response and a 2.40 increased risk of infusion reactions. [91] However, it is clear from these studies ...

Background/Aims Infliximab is currently used for the treatment of moderate-to-severe ulcerative colitis (UC ... who received at least one infliximab infusion for UC. Short- and long-term clinical ...

Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA ® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of ...